LITTLE ELM, Texas–(BUSINESS WIRE)–Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $10.1 million for the third quarter of 2025 and an operating loss of $3.7 million for the period, as compared to total net sales for the same period last year of $10.3 million and an operating loss of $5.1 million. For … [Read more…]
CERRITOS, Calif.–(BUSINESS WIRE)–HealthView is proud to announce that its Chief Executive Officer, Steven Gonzalez, has published his first article in Inc. Magazine, marking an important milestone for the organization’s expanding leadership voice. His debut piece, “3 Leadership Lessons From Surfing,” explores how the uncertainty of the ocean mirrors the realities of modern leadership—highlighting adaptability, balance, … [Read more…]
Community Event at SBH Health & Wellness Center Supports Bronx Residents During Diabetes Prevention Month BRONX, N.Y.–(BUSINESS WIRE)–Healthfirst, a leading not-for-profit health plan serving more than two million New Yorkers, today is hosting a community event focused on diabetes prevention and management at SBH Health & Wellness Center in the Bronx. This forum, co-hosted with … [Read more…]
Appointed Mark Nawacki, seasoned M&A expert, co-founder, president & former CEO of Searchlight Pharma, to Board of Directors Completed IND submission to the U.S. FDA and global regulatory filings to advance a Phase 2 clinical trial of SAT-3247 in children with Duchenne muscular dystrophy (DMD) Dosed first patient in open-label, long-term follow-up study (LT-001) of … [Read more…]
ZUG, Switzerland–(BUSINESS WIRE)–NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION. Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced the successful placement of a single-tranche CHF 175 million Swiss franc-denominated bond. The bond has a maturity of … [Read more…]
NEW YORK & BOSTON–(BUSINESS WIRE)–TandemAI announced it has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced AI, physics-based computational methods, and wet lab capabilities. The round included both new and existing investors. Since its founding in October 2021, the company has raised over $80M. With a … [Read more…]
P3 Reports Continued Operational Progress and Expansion of Care Enablement Model in a Transitional Year $120 to $170 Million EBITDA Expansion Opportunity Strengthens Path to Meaningful Profitability Management to Host Conference Call and Webcast November 14, 2025 at 8:00 AM ET HENDERSON, Nev.–(BUSINESS WIRE)–P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered … [Read more…]
Key Highlights ZUNVEYL Launch Momentum: Completed the second quarter of commercialization, generating approximately $2.8 million in total revenue for the quarter. Significant Growth: 102% quarterly increase in pharmacy orders, with record prescription volumes achieved each month during the quarter. Expanding Prescriber Base: Q3 prescribers surpassed 500, representing 55% growth over the prior quarter. Disciplined Expense … [Read more…]
CAMBRIDGE, England–(BUSINESS WIRE)–biomodal, an omics-based life sciences technology and analytics company, today announced it has filed a lawsuit against Watchmaker Genomics (“Watchmaker”) in the United States District Court for the District of Colorado. The lawsuit seeks damages and a court order to stop Watchmaker from making, using, selling, or offering for sale their TAPS+ product, … [Read more…]
Welldoc’s Strategic Investment Accelerates Research and Development of Novel AI-Powered Hyper-personalization Capabilities at Scale COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced the formal launch of the Welldoc AI Lab and confirmed a significant milestone of over 100 peer-reviewed clinical publications, including 43 dedicated to advanced AI. Together with the company’s … [Read more…]
